Rebleeding risk rises with transfusions for patients with NVUGIB

01/31/2013 | Healio

A study published in Alimentary Pharmacology & Therapeutics linked red blood cell transfusions with increased rebleeding risk in patients with nonvariceal upper gastrointestinal bleeding. Transfusions also were associated with greater all-cause mortality. The study of 1,677 patients was limited, according to researchers, but the findings "support the need for a prospective randomized trial."

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN